MicroRNA and cancer.

Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res (2013) 1.92

MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer. Theranostics (2015) 1.62

DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. Gastric Cancer (2014) 1.56

A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance. Br J Cancer (2016) 1.43

In vivo delivery of miRNAs for cancer therapy: challenges and strategies. Adv Drug Deliv Rev (2014) 1.28

Uptake and Function Studies of Maternal Milk-derived MicroRNAs. J Biol Chem (2015) 1.15

miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer. Oncogene (2014) 1.15

MiRNA-based therapeutic intervention of cancer. J Hematol Oncol (2015) 1.14

Global population-specific variation in miRNA associated with cancer risk and clinical biomarkers. BMC Med Genomics (2014) 1.13

miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma. Oncotarget (2014) 1.12

MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor gamma in human hepatocellular carcinoma. Int J Mol Sci (2014) 1.12

MicroRNAs as potential biomarkers in cancer: opportunities and challenges. Biomed Res Int (2015) 1.12

MicroRNA (miRNA) in cancer. Cancer Cell Int (2015) 1.06

MiR-19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP-2 expression. Int J Clin Exp Pathol (2013) 1.06

Exosomal miRNAs as Biomarkers for Prostate Cancer. Front Genet (2013) 1.06

miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25. Mol Cancer (2014) 1.05

MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling. Oncotarget (2014) 1.04

Noncoding RNA in age-related cardiovascular diseases. J Mol Cell Cardiol (2015) 1.04

AEG-1/MTDH/LYRIC, the beginning: initial cloning, structure, expression profile, and regulation of expression. Adv Cancer Res (2013) 1.03

Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis. J Clin Invest (2013) 1.03

miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells. Oncotarget (2015) 1.00

Breast cancer intrinsic subtype classification, clinical use and future trends. Am J Cancer Res (2015) 1.00

MicroRNAs in colorectal cancer as markers and targets: Recent advances. World J Gastroenterol (2014) 0.98

miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer. Int J Clin Exp Pathol (2014) 0.98

The role of epithelial plasticity in prostate cancer dissemination and treatment resistance. Cancer Metastasis Rev (2014) 0.94

Dysregulation of microRNA biogenesis in cancer: the impact of mutant p53 on Drosha complex activity. J Exp Clin Cancer Res (2016) 0.94

MicroRNA theragnostics for the clinical management of multiple myeloma. Leukemia (2013) 0.93

Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age. Sci Rep (2015) 0.93

Up-regulation of miR-630 in clear cell renal cell carcinoma is associated with lower overall survival. Int J Clin Exp Pathol (2014) 0.92

MicroRNA-21-3p, a berberine-induced miRNA, directly down-regulates human methionine adenosyltransferases 2A and 2B and inhibits hepatoma cell growth. PLoS One (2013) 0.92

MicroRNA-26a regulates glucose metabolism by direct targeting PDHX in colorectal cancer cells. BMC Cancer (2014) 0.91

MicroRNA polymorphisms and environmental smoke exposure as risk factors for oesophageal squamous cell carcinoma. PLoS One (2013) 0.91

A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma. J Cancer Res Clin Oncol (2015) 0.90

MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1. Oncotarget (2016) 0.90

Regulation of multidrug resistance proteins by genistein in a hepatocarcinoma cell line: impact on sorafenib cytotoxicity. PLoS One (2015) 0.89

Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer. Int J Clin Exp Pathol (2014) 0.89

Axl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancer. Cell Death Dis (2014) 0.89

Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma. Onco Targets Ther (2013) 0.89

miR-30e* is an independent subtype-specific prognostic marker in breast cancer. Br J Cancer (2015) 0.89

miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway. Cell Oncol (Dordr) (2015) 0.89

Overview of the biochemical and genetic processes in malignant mesothelioma. J Bras Pneumol (2014) 0.88

The Potential of MicroRNAs as Prostate Cancer Biomarkers. Eur Urol (2016) 0.88

Prognostic significance of microRNA-16 expression in human colorectal cancer. World J Surg (2013) 0.88

MicroRNA expression profiles predict clinical phenotypes and prognosis in chromophobe renal cell carcinoma. Sci Rep (2015) 0.87

Up-regulation of miR-335 predicts a favorable prognosis in esophageal squamous cell carcinoma. Int J Clin Exp Pathol (2014) 0.87

Interactions between cancer cells and normal cells via miRNAs in extracellular vesicles. Cell Mol Life Sci (2015) 0.87

MicroRNA- 130b suppresses migration and invasion of colorectal cancer cells through downregulation of integrin β1 [corrected]. PLoS One (2014) 0.87

A microRNA signature profile in EBV+ diffuse large B-cell lymphoma of the elderly. Oncotarget (2014) 0.86

Iron and cancer: recent insights. Ann N Y Acad Sci (2016) 0.86

Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2. Oncogene (2014) 0.85

Cancer diagnostic classifiers based on quantitative DNA methylation. Expert Rev Mol Diagn (2014) 0.85

miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents. Future Med Chem (2014) 0.84

MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential. J Zhejiang Univ Sci B (2015) 0.84

miR-21 coordinates tumor growth and modulates KRIT1 levels. Biochem Biophys Res Commun (2013) 0.84

H-ferritin-regulated microRNAs modulate gene expression in K562 cells. PLoS One (2015) 0.83

MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer. J Ovarian Res (2015) 0.83

Identification and characterization of microRNAs in the ovaries of multiple and uniparous goats (Capra hircus) during follicular phase. BMC Genomics (2014) 0.83

MicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targets. J Thorac Dis (2015) 0.82

Evaluation of MicroRNAs Regulating Anoikis Pathways and Its Therapeutic Potential. Biomed Res Int (2015) 0.82

Tumor invasion and metastasis regulated by microRNA-184 and microRNA-574-5p in small-cell lung cancer. Oncotarget (2015) 0.82

Genomics, personalized medicine, and pediatrics. Acad Pediatr (2013) 0.82

Altered expression of miR-24, miR-126 and miR-365 does not affect viability of childhood TCF3-rearranged leukemia cells. Leukemia (2013) 0.81

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors. Invest New Drugs (2016) 0.81

Sleepless latency of human cytomegalovirus. Med Microbiol Immunol (2015) 0.81

The Reverse Transcriptase Encoded by LINE-1 Retrotransposons in the Genesis, Progression, and Therapy of Cancer. Front Chem (2016) 0.81

miRNA signature of mouse helper T cell hyper-proliferation. PLoS One (2013) 0.81

Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma. Oncotarget (2016) 0.81

Basic fibroblast growth factor promotes VEGF-C-dependent lymphangiogenesis via inhibition of miR-381 in human chondrosarcoma cells. Oncotarget (2016) 0.80

High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis. PLoS One (2014) 0.80

FAM46 proteins are novel eukaryotic non-canonical poly(A) polymerases. Nucleic Acids Res (2016) 0.80

Inferred miRNA activity identifies miRNA-mediated regulatory networks underlying multiple cancers. Bioinformatics (2015) 0.80

Small regulatory RNAs in Archaea. RNA Biol (2014) 0.80

MiR-133b regulates the expression of the Actin protein TAGLN2 during oocyte growth and maturation: a potential target for infertility therapy. PLoS One (2014) 0.80

Quercetin Decreases Claudin-2 Expression Mediated by Up-Regulation of microRNA miR-16 in Lung Adenocarcinoma A549 Cells. Nutrients (2015) 0.80

Suberoylanilide hydroxamic acid inhibits growth of head and neck cancer cell lines by reactivation of tumor suppressor microRNAs. Oral Oncol (2016) 0.80

Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins. MBio (2017) 0.80

miR-152 as a tumor suppressor microRNA: Target recognition and regulation in cancer. Oncol Lett (2016) 0.80

Small molecules targeting microRNA for cancer therapy: Promises and obstacles. J Control Release (2015) 0.80

A microrna screen to identify regulators of peritoneal fibrosis in a rat model of peritoneal dialysis. BMC Nephrol (2015) 0.79

Expression Profiles and Clinical Significance of MicroRNAs in Papillary Renal Cell Carcinoma: A STROBE-Compliant Observational Study. Medicine (Baltimore) (2015) 0.79

Genetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African-American men. Prostate Cancer Prostatic Dis (2013) 0.79

Identification of genes with consistent methylation levels across different human tissues. Sci Rep (2014) 0.79

Sjögren's syndrome-associated microRNAs in CD14(+) monocytes unveils targeted TGFβ signaling. Arthritis Res Ther (2016) 0.79

Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas. Oncotarget (2016) 0.79

MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases. Best Pract Res Clin Endocrinol Metab (2016) 0.78

Cell survival is dicey without Dicer. Mol Cell Oncol (2014) 0.78

The emerging role of extracellular vesicle-derived miRNAs: implication in cancer progression and stem cell related diseases. J Clin Epigenet (2016) 0.78

Current Perspectives on Epigenetic Modifications by Dietary Chemopreventive and Herbal Phytochemicals. Curr Pharmacol Rep (2015) 0.78

Understanding the interaction of hepatitis C virus with host DEAD-box RNA helicases. World J Gastroenterol (2014) 0.78

miR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma. Int J Clin Exp Pathol (2015) 0.78

MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression. Mol Cancer (2016) 0.78

Paternal overweight is associated with increased breast cancer risk in daughters in a mouse model. Sci Rep (2016) 0.78

The Regulation of Reverse Cholesterol Transport and Cellular Cholesterol Homeostasis by MicroRNAs. Biology (Basel) (2015) 0.78

Epigenetic regulation of drug metabolism and transport. Acta Pharm Sin B (2015) 0.78

MicroRNA in Cancer and Cachexia--A Mini-Review. J Infect Dis (2015) 0.78

miR-155 as a Biomarker in B-Cell Malignancies. Biomed Res Int (2016) 0.78

MiR-193b promotes autophagy and non-apoptotic cell death in oesophageal cancer cells. BMC Cancer (2016) 0.78

Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology. Mol Ther (2016) 0.78

MicroRNAs in melanoma development and resistance to target therapy. Oncotarget (2017) 0.78

MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis. Oncotarget (2016) 0.78

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem (2007) 7.46

RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell (2007) 7.06

MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell (2008) 6.58

LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene (2006) 3.49

Stable X chromosome inactivation involves the PRC1 Polycomb complex and requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3 ligase. Proc Natl Acad Sci U S A (2005) 2.81

miR-200b mediates post-transcriptional repression of ZFHX1B. RNA (2007) 2.67

microRNA-101 is a potent inhibitor of autophagy. EMBO J (2011) 2.00

A high-throughput splinkerette-PCR method for the isolation and sequencing of retroviral insertion sites. Nat Protoc (2009) 1.95

MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. Cell Cycle (2011) 1.89

Isolation of microRNA targets using biotinylated synthetic microRNAs. Methods (2007) 1.69

MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS One (2010) 1.64

MicroRNA regulation of autophagy. Carcinogenesis (2012) 1.56

miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer (2011) 1.46

Experimental identification of microRNA targets. Gene (2009) 1.36

PRDM proteins: important players in differentiation and disease. Bioessays (2011) 1.28

microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus. Sci Rep (2013) 1.18

MicroRNA-143 down-regulates Hexokinase 2 in colon cancer cells. BMC Cancer (2012) 1.16

MicroRNA 10a marks regulatory T cells. PLoS One (2012) 1.09

Chromatin-modifying proteins in cancer. APMIS (2007) 1.04

Insertional mutagenesis in mice deficient for p15Ink4b, p16Ink4a, p21Cip1, and p27Kip1 reveals cancer gene interactions and correlations with tumor phenotypes. Cancer Res (2010) 1.02

The miR-10 microRNA precursor family. RNA Biol (2011) 0.97

microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer. Mol Cancer (2012) 0.95

Loss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female mice. PLoS Genet (2013) 0.91

Identification of expressed and conserved human noncoding RNAs. RNA (2013) 0.89

MiR-492 impairs the angiogenic potential of endothelial cells. J Cell Mol Med (2013) 0.86

miRConnect: identifying effector genes of miRNAs and miRNA families in cancer cells. PLoS One (2011) 0.82

Impairment of alternative splice sites defining a novel gammaretroviral exon within gag modifies the oncogenic properties of Akv murine leukemia virus. Retrovirology (2007) 0.81

Target-cell-derived tRNA-like primers for reverse transcription support retroviral infection at low efficiency. Virology (2002) 0.81

PRDM11 is dispensable for the maintenance and function of hematopoietic stem and progenitor cells. Stem Cell Res (2013) 0.77

Epigenetic dynamics across the cell cycle. Essays Biochem (2010) 0.76